Abstract

ObjectivesTo examine the role of psychological defense mechanisms (PDM) and level of subjective control (LSC) in the development of affective disorders in patients with rheumatoid arthritis (RA).MethodsWe observed 28 patients...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The Use of Biological Feedback in Complex Treatment of Patients with Rheumatoid Arthritis and Systemic Sclerosis
M Levkina ... L Shilova
KnE Life Sciences | VOL. 4
M Levkina, et. al.M Levkina ... L Shilova
01 Nov 2018
Estimation of typological delineation of emotional-dynamic pattern in practically healthy ukrainian women without and taking into account somatotype
О Ye Maievskyi ... R L Stepanenko
Reports of Vinnytsia National Medical University | VOL. 25
О Ye Maievskyi, et. al.О Ye Maievskyi ... R L Stepanenko
30 Nov 2021
Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis
You Song ... Jing Yuan
Journal of Lipid Research | VOL. 52
You Song, et. al.You Song ... Jing Yuan
01 May 2011
Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis
Xia Ye ... Zhuoli Zhang
Advances in Rheumatology | VOL. 62
Xia Ye, et. al.Xia Ye ... Zhuoli Zhang
20 Jun 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers